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1. Introduction 
A large mass of research has been accumulating to provide evidence for the health benefits 
of olive oil feeding and to scientifically support the widespread adoption of traditional 
Mediterranean diet as a model of healthy eating (Menendez et al., 2007). This evidence has 
been attributed to the fact that olive oil, the predominant source of fat in the Mediterranean 
diet (Petroni et al., 1995), contains several minor non-nutrients chemicals such as α- and γ-
tocopherols and β-carotene, phytosterols, pigments, terpenic acids, flavonoids such as 
luteolin and quercetin, squalene, and phenolic compounds, usually and incorrectly termed 
polyphenols (Menendez et al., 2007; Visioli et al., 2002; Trichopoulou et al., 2003; Tripoli et al., 
2005; Servili et al., 2004). The main phenolic compounds in virgin olive oil are secoiridoid 
derivatives of 2-(3,4-dihydroxyphenyl)ethanol (3,4-DHPEA) and 2-(4-hydroxyphenyl)-
ethanol (p-HPEA) that occur as either simple phenols or esterified with elenolic acid to form, 
respectively, oleuropein and its derivative demethyloleuropein, and ligstroside, their 
aglycones 3,4-DHPEA-EA and p-HPEA-EA (Figure 1) (Bendini et al., 2007; Suárez et al., 
2009). The aglyconic form of oleuropein and ligstroside, 3,4-DHPEA-EA and p-HPEA-EA 
respectively, were reported for the first time by Montedoro et al, who also assigned their 
chemical structures, later confirmed by other (Montedoro et al., 1992; Angerosa et al., 1996; 
Owen et al., 2000). 3,4-DHPEA-EA and p-HPEA-EA, associated to the intense sensory of 
bitterness and pungency respectively attribute in VOO (Gutierrez-Rosales et al., 2003), is 
endowed with numerous beneficial effects on human health (Servili et al., 2004; Bendini et 
al., 2007; Esti et al., 1998; Della Ragione et al., 2000; Paiva-Martins et al., 2001; Fabiani et al., 
2002; Carasco-Pancorbo et al., 2005; Artajo et al., 2006; Fabiani et al., 2006; Fabiani et al., 2008; 
Paiva-Martins et al., 2009).  
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Figure 1. Chemical structures.  
In particular, the anti-inflammatory properties of olive oil phenolic compounds seem to 
overlap with those attributed to non-steroidal anti-inflammatory drugs (Procopio A, et al., 
2009). The majority of phenolic compounds found in olive oil or table olives are derived 
from the hydrolysis of oleuropein, the major phenolic constituent of the leaves and 
unprocessed olive drupes of Olea europaea and responsible for the bitter taste of immature 
and unprocessed olives. Concentrations of up to 9.0 mg/l of oleouropein and 5.6 mg/l of its 
hydrolysis product hydroxytyrosol, have been detected in some preparations of olive oil 
(Montedoro et al., 1992). Oleuropein, a glucoside with hydroxyaromatic functionality, has 
recognized several pharmacological properties including antioxidant, anti-inflammatory, 
anti-atherogenic, anti-cancer, antidiabetic, antimicrobial, and antiviral, and for these 
reasons, it is commercially available as food supplement in Mediterranean countries (Miles 
et al., 2005; Covas, 2008; Omar, 2010). A more efficient anti-inflammatory role of the 
aglyconic 3,4-DHPEA-EA compared with the glycosidic form of oleuropein possibly derives 
from the greater lipophilicity of the former, a property that should allow better cell 
membrane incorporation and/or interaction with other lipids (Saija et al., 1998). We focused 
on the antinflammatory properties of 3,4-DHPEA-EA, a hydrolysis product obtained from 
Oleuropein by the action of β-glucosidase on the parent glucoside, has been evaluated in a 
mice model of acute inflammation (carrageenan-induced pleurisy) and in a mice model of 
chronic inflammation (collagen-induced arthritis) (Impellizzeri et al., 2011a-b). 
2. 3,4-DHPEA-EA and acute inflammation 
Premise - The inflammatory reaction is characterized by an initial increase in blood flow to 
the site of injury, enhanced vascular permeability, production of mediators such us 
prostaglandins, leukotrienes, histamine, bradykinin, platelet-activating factor (PAF) and the 
ordered and directional influx and selective accumulation of different effector cells from the 
peripheral blood at the site of injury. Influx of antigen non-specific but highly destructive 
cells (neutrophils) is one of the earliest stages of the inflammatory response. Carrageenan-
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steroidal drugs (NSAIDs). Therefore, carrageenan-induced local inflammation (pleurisy) is a 
useful model to assess the contribution of mediators involved in cellular alterations during 
the inflammatory process. In particular, the initial phase of acute inflammation (0-1h) which 
is not inhibited by NSAIDs such as indomethacin or aspirin, has been attributed to the 
release of histamine, 5-hydroxytryptamine and bradykinin, followed by a late phase (1-6 h) 
mainly sustained by prostaglandin release and attributed to the induction of inducible 
cyclo-oxygenase (COX-2) in the tissue (Nantel et al., 1999). It appears that the onset of the 
carrageenan-induced acute inflammation has been linked to neutrophil infiltration and the 
production of neutrophil-derived free radicals, such as hydrogen peroxide, superoxide and 
hydroxyl radical, as well as the release of other neutrophil-derived mediators. Free radicals 
are produced in small amounts by normal cellular processes as part of the mitochondrial 
electron transport chain and the microsomal cytochrome P-450 system. They are formed 
during traumatic or hypoxic injuries as a consequence of insufficient oxygenation.  Reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) can react with and subsequently 
damage proteins, nucleic acids, lipids, and extracellular matrix proteins. During the 
inflammatory response, ROS and RNS modulate phagocytosis, secretion, gene expression, 
and apoptosis. Indeed, under pathological circumstances such as acute lung injury and 
sepsis, excess production of neutrophil-derived ROS and RNS may influence neighbouring 
endothelial or epithelial cells, contributing to the amplification of inflammatory tissue 
injury (Fialkow et al., 2007). Furthermore, oxidative stress elicits the activation of the 
redox-sensitive transcription factors such as nuclear factor-κB (NF-κB) and AP-1, that play 
a central and crucial role in inducing the expression of inflammatory cytokines and 
intercellular adhesion molecule (ICAM-1) (Chen et al., 2004) and the activation of the 
redox-sensitive protein kinases such as the mitogen-activated protein kinase (MAPK) 
superfamily (Li et al., 2002). Thus, the study model was designed to evaluate the effects of 
3,4-DHPEA-EA in a mice model of acute inflammation (0.1 ml of saline containing 2% λ-
carrageenan was injected into the pleural cavity). In particular, we investigated the effects 
of 3,4-DHPEA-EA on the lung injury associated with carrageenan induced pleurisy. In 
order to gain a better insight into the mechanism of action of 3,4-DHPEA-EA, we have 
also investigated the effects on: 1) lung damage (histology), 2) polymorphonuclear (PMN) 
infiltration (myeloperoxidase [MPO] activity), 3) ICAM-1 and platelet-adhesion-molecule 
(P-selectin) expression, 4) nitrotyrosine and poly-ADP-ribose (PAR) formation, 5) pro-
inflammatory cytokines production, tumor necrosis factor-α (TNF-α) and interleukin-1β 
(IL-1β), 6) lipid peroxidation (malondialdehyde [MDA] levels), and 7) nitric oxide (NO) 
synthesis (nitrite-nitrate concentration). 
2.1. Materials and methods 
Animals - Male CD mice, weight 20-25 g; Harlan Nossan, Milan, Italy, were used in these 
studies. The animals were housed in a controlled environment and provided with standard 
rodent chow and water. Animal care was in compliance with Italian regulations on the 
protection of animals used for experimental and other scientific purposes (D.lgs 116/92) as 
well as with EEC regulations (O.J. of E.C. L358/1 12/18/1986). 
 
Olive Germplasm – The Olive Cultivation, Table Olive and Olive Oil Industry in Italy 290 
Carrageenan-induced pleurisy - Carrageenan-induced pleurisy was induced as previously 
described (Cuzzocrea et al., 1999). Mice were anaesthetized with isoflurane and subjected to 
a skin incision at the level of the left sixth intercostals space. The underlying muscle was 
dissected and saline (0.1 ml) or saline containing 2% λ-carrageenan (0.1 ml) was injected into 
the pleural cavity. The skin incision was closed with a suture and the animals were allowed 
to recover. At 4 h after the injection of carrageenan, the animals were killed by inhalation of 
CO2. The chest was carefully opened and the pleural cavity rinsed with 1 ml of saline 
solution containing heparin (5 U ml-1) and indomethacin (10 µg ml-1). The exudate and 
washing solution were removed by aspiration and the total volume measured. Any exudate, 
which was contaminated with blood, was discarded. 
Experimental Design - Mice were randomly allocated into the following groups: (i) CAR + 
saline group. Mice were subjected to carrageenan-induced pleurisy (N = 10); (ii) CAR + 3,4-
DHPEA-EA group (100 µM/kg). Same as the CAR + saline group but 3,4-DHPEA-EA (100 
µM/kg, i.p.) were administered 30min after to carrageenan (N = 10); (iii) CAR + 3,4-DHPEA-
EA group (40 µM/kg). Same as the CAR + saline group but 3,4-DHPEA-EA (40 µM/kg, i.p.) 
were administered 30min after to carrageenan (N = 10); (iv) Sham + saline group. Sham-
operated group in which identical surgical procedures to the CAR group was performed, 
except that the saline was administered instead of carrageenan (N = 10); (v) Sham + 3,4-
DHPEA-EA group. Same as the Sham+saline group but 3,4-DHPEA-EA (100 µM /kg, i.p.) 
were administered 30min after to carrageenan (N = 10). The doses of 3,4-DHPEA-EA (40 and 
100 µ M /kg, i.p.) used here were based on previous in vivo studies (Procopio A, et al., 2009). 
Histological examination - Lung tissues samples were taken 4 h after injection of carrageenan. 
Lung tissues samples were fixed for 1 week in 10 % (w/v) PBS-buffered formaldehyde 
solution at room temperature, dehydrated using graded ethanol and embedded in Paraplast 
(Sherwood Medical, Mahwah, NJ, USA). Sections were then deparaffinized with xylene, 
stained with hematoxylin and eosin. All sections were studied using Axiovision Zeiss 
(Milan, Italy) microscope. 
Measurement of cytokines - TNF-α and IL-1β levels were evaluated in the exudate 4 h after the 
induction of pleurisy by carrageenan injection as previously described (Cuzzocrea et al., 
1999). The assay was carried out using a colorimetric commercial ELISA kit (Calbiochem-
Novabiochem Corporation, Milan, Italy). 
Measurement of nitrite-nitrate concentration - Total nitrite in exudates, an indicator of NO 
synthesis, was measured as previously described (Cuzzocrea et al., 2001). Briefly, the nitrate 
in the sample was first reduced to nitrite by incubation with nitrate reductase (670 mU/ml) 
and β-nicotinamide adenine dinucleotide 3’-phosphate (NADPH) (160 µM) at room 
temperature for 3 h. The total nitrite concentration in the samples was then measured using 
the Griess reaction, by adding 100 µl of Griess reagent (0.1% w/v) naphthylethylendiamide 
dihydrochloride in H2O and 1% (w/v) sulphanilamide in 5% (v/v) concentrated H3PO4; vol. 
1:1) to the 100 µl sample. The optical density at 550 nm (OD550) was measured using ELISA 
microplate reader (SLT-Lab Instr., Salzburg, Austria). Nitrite concentrations were calculated 
by comparison with OD550 of standard solutions of sodium nitrite prepared in H2O. 
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Immunohistochemical localization of ICAM-1, P-selectin, nitrotyrosine and PAR - At the end of 
the experiment, the tissues were fixed in 10% (w/v) PBS-buffered formaldehyde and 8 µm 
sections were prepared from paraffin embedded tissues. After deparaffinization, 
endogenous peroxidase was quenched with 0.3% (v/v) hydrogen peroxide in 60% (v/v) 
methanol for 30 min. The sections were permeablized with 0.1% (w/v) Triton X-100 in PBS 
for 20 min. Non-specific adsorption was minimized by incubating the section in 2% (v/v) 
normal goat serum in PBS for 20 min. Endogenous biotin or avidin binding sites were 
blocked by sequential incubation for 15 min with biotin and avidin, respectively. Sections 
were incubated overnight with anti-nitrotyrosine rabbit polyclonal antibody (Upstate, 1:500 
in PBS, v/v), anti-PAR antibody (BioMol, 1:200 in PBS, v/v), anti-ICAM-1 antibody (Santa 
Cruz Biotechnology, 1:500 in PBS, v/v) or with anti-P-selectin polyclonal antibody (Santa 
Cruz Biotechnology, 1:500 in PBS, v/v). Sections were washed with PBS, and incubated with 
secondary antibody. Specific labeling was detected with a biotin-conjugated goat anti-rabbit 
IgG and avidin-biotin peroxidase complex (Vector Laboratories, DBA). In order to confirm 
that the immunoreaction for the nitrotyrosine was specific, some sections were also 
incubated with the primary antibody (anti-nitrotyrosine) in the presence of excess 
nitrotyrosine (10 mM) to verify the binding specificity. To verify the binding specificity for 
PAR, ICAM-1, P-selectin, some sections were also incubated with only the primary antibody 
(no secondary) or with only the secondary antibody (no primary). In these situations no 
positive staining was found in the sections indicating that the immunoreaction was positive 
in all the experiments carried out.  
MPO activity - MPO activity, an indicator of PMN accumulation, was determined as 
previously described (Mullane et al., 1985). At the specified time following injection of 
carrageenan, lung tissues were obtained and weighed, each piece homogenized in a solution 
containing 0.5% (w/v) hexadecyltrimethyl-ammonium bromide dissolved in 10 mM 
potassium phosphate buffer (pH 7) and centrifuged for 30 min at 20,000 x g at 4°C. An 
aliquot of the supernatant was then allowed to react with a solution of tetramethylbenzidine 
(1.6 mM) and 0.1 mM H2O2. The rate of change in absorbance was measured 
spectrophotometrically at 650 nm. MPO activity was defined as the quantity of enzyme 
degrading 1 µmol of peroxide min-1 at 37°C and was expressed in milliunits per gram 
weight of wet tissue. 
MDA measurement - MDA levels in the lung tissue were determined as an indicator of lipid 
peroxidation as previously described (Ohkawa et al., 1979). Lung tissue collected at the 
specified time, was homogenized in 1.15% (w/v) KCl solution. A 100 µl aliquot of the 
homogenate was added to a reaction mixture containing 200 µl of 8.1% (w/v) SDS, 1.5 ml of 
20% (v/v) acetic acid (pH 3.5), 1.5 ml of 0.8% (w/v) thiobarbituric acid and 700 µl distilled 
water. Samples were then boiled for 1 h at 95°C and centrifuged at 3,000 x g for 10 min. The 
absorbance of the supernatant was measured using spectrophotometry at 650 nm. 
Materials - Unless otherwise stated, all compounds were obtained from Sigma-Aldrich 
Company Ltd. (Poole, Dorset, U.K.). 3,4-DHPEA-EA was obtained from the controlled 
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hydrolysis of oleuropein extracted from olive leaves by means the patented method reported 
by Procopio et al. (2009). All other chemicals were of the highest commercial grade available. 
All stock solutions were prepared in non-pyrogenic saline (0.9% NaCl; Baxter, Italy, UK). 
Statistical evaluation - All values in the figures and text are expressed as mean  standard 
error (s.e.m.) of the mean of n observations. For the in vivo studies n represents the number 
of animals studied. In the experiments involving histology or immunohistochemistry, the 
figures shown are representative of at least three experiments (histological or 
immunohistochemistry coloration) performed on different experimental days on the tissue 
sections collected from all the animals in each group. The results were analyzed by one-way 
ANOVA followed by a Bonferroni post-hoc test for multiple comparisons. A p-value less 
than 0.05 were considered significant and individual group means were then compared 
with Student's unpaired t test. A p-value of less than 0.05 was considered significant. 
2.2. Results 
Effects of 3,4-DHPEA-EA on carrageenan-induced pleurisy – When compared to lung sections 
taken from saline-treated animals (sham group Fig. 2A, see histological score 2D) 
histological examination of lung sections taken from mice treated with carrageenan revealed 
significant tissue damage and edema (Fig. 2B, see histological score 2D) as well as 
infiltration of neutrophils (PMNs) within the tissues (Fig. 2B). 3,4-DHPEA-EA (100 µM/kg) 
reduced the degree of lung injury (Fig. 2C, see histological score 2D). The pleural infiltration 
with PMN appeared to correlate with an influx of leukocytes into the lung tissue, thus we 
investigated the effect of 3,4-DHPEA-EA on neutrophil infiltration by measurement of MPO 
activity. MPO activity was significantly elevated at 4 h after carrageenan administration in 
vehicle-treated mice (Fig. 2E). Treatment with 3,4-DHPEA-EA significantly attenuated 
neutrophil infiltration into the lung tissue (Fig. 2E).  
Effects of 3,4-DHPEA-EA on the expression of adhesion molecules (ICAM-1, P-selectin) - Staining 
of lung tissue sections obtained from saline-treated mice with anti-ICAM-1 antibody 
showed a specific staining along bronchial epithelium demonstrating that ICAM-1 is 
constitutively expressed (Fig. 3A). No positive staining for P-selectin was found in lung 
tissue sections from saline-treated mice (Fig. 3D). At 4 h after carrageenan injection, the 
ICAM-1 staining intensity increased in the vascular endothelium (Fig. 3B). Lung tissue 
sections obtained from carrageenan-treated mice showed positive staining for P-selectin 
localized in the vessels (Fig. 3E). No positive staining for ICAM-1 or P-selectin was observed 
in the lungs of carrageenan-treated mice treated with 3,4-DHPEA-EA (Fig. 3C and 3F 
respectively). 
Effects of 3,4-DHPEA-EA on the release of pro-inflammatory cytokine and nitrite–nitrate 
concentration - When compared to sham animals, injection of carrageenan resulted in an 
increase in the levels of TNF-α and IL-1β in the pleural exudates (Fig. 4A,B). The release 
of TNF-α and IL-1β was significantly attenuated by treatment with 3,4-DHPEA-EA (Fig. 
4A,B).  
 






Figure 2. Effect of 3,4-DHPEA-EA (Ole aglycone) on histological alterations of lung tissue 4 h after 
carrageenan-induced injury and on PMN infiltration in the lung. Lung sections taken from carrageenan-
treated mice treated with vehicle demonstrated edema, tissue injury (B) as well as infiltration of the 
tissue with neutrophils (B). Carrageenan-treated animals treated with 3,4-DHPEA-EA   
(C) demonstrated reduced lung injury and neutrophil infiltration. Section from sham animals 
demonstrating the normal architecture of the lung tissue (A). The histological score (D) was made by an 
independent observer. MPO activity, index of PMN infiltration, was significantly elevated at 4 h after 
carrageenan (CAR) administration in vehicle-treated mice (E), if compared with sham mice (E). 3,4-
DHPEA-EA significantly reduced MPO activity in the lung (E). The figure is representative of at least 3 
experiments performed on different experimental days. Data are expressed as mean ± S.E.M. from  
n = 10 mice for each group. **, P < 0.01 versus sham group. ##, P < 0.01 versus carrageenan. 
No significant increase of TNF-α and IL-1β exudates levels was found in the sham animal 
(Fig. 4A,B). NO levels were also significantly increased in the exudate obtained from mice 
administered carrageenan (Fig. 4C). Treatment of mice with 3,4-DHPEA-EA significantly 
reduced NO exudates levels (Fig. 4C). No significant increase of NO exudates levels was 
found in the sham animal (Fig. 4C). 
Effects of 3,4-DHPEA-EA on carrageenan-induced nitrotyrosine formation, lipid 
peroxidation and poly-ADP-ribosyl polymerase (PARP) activation - Immunohistochemical 
analysis of lung sections obtained from mice treated with carrageenan revealed positive 
staining for nitrotyrosine (Fig. 5B). In contrast, no positive staining for nitrotyrosine was 
found in the lungs of carrageenan-treated mice, which had been treated with 3,4-DHPEA-
EA (100 µM/kg) (Fig. 5C). In addition, at 4 hours after carrageenan-induced pleurisy, MDA 
levels were also measured in the lungs as an indicator of lipid peroxidation. As shown in 
Figure 5D, MDA levels were significantly increased in the lungs of carrageenan-treated 
mice. Lipid peroxidation was significantly attenuated by the intraperitoneal injection of 
3,4-DHPEA-EA (Fig. 5D). At the same time point (4 h after carrageenan administration), 
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lung tissue sections were taken in order to determine the immunehistological staining for 
poly ADP-ribosylated proteins (an indicator of PARP activation). A positive staining for 
the PAR (Fig. 5F) was found primarily localized in the inflammatory cells present in the 
lung tissue from carrageenan-treated mice. 3,4-DHPEA-EA treatment reduced the degree 
of PARP activation (Fig. 5G). Please note that there was no staining for either 













Figure 3. Effect of 3,4-DHPEA-EA (Ole aglycone) on the immunohistochemical localization of ICAM-1 
and P-selectin in the lung after carrageenan injection. No positive staining for ICAM-1 was observed in 
lung sections taken from sham mice (A). Lung sections taken from carrageenan-treated mice showed 
intense positive staining for ICAM-1 along the vessels (B). The degree of positive staining for ICAM-1 
was markedly reduced in lung sections obtained from mice treated with 3,4-DHPEA-EA  (C). No 
positive staining for P-selectin was observed in lung sections taken from sham mice (D). Lung sections 
taken from carrageenan-treated mice treated with vehicle showed intense positive staining for P-
selectin along the vessels (E). The degree of positive staining for P-selectin was markedly reduced in 
tissue sections obtained from mice treated with 3,4-DHPEA-EA (F). The figure is representative of at 
least three experiments performed on different experimental days. 
 
















Figure 4. Effect of 3,4-DHPEA-EA (Ole aglycone) on  carrageenan-induced pro-inflammatory cytokine 
release and NO formation in the lung. TNF-α and Il-1β levels were significantly elevated at 4 h after 
carrageenan administration in vehicle-treated mice (A and B respectively), if compared with sham mice 
(A and B respectively). 3,4-DHPEA-EA significantly reduced TNF-α and Il-1β levels (A and B 
respectively). Moreover nitrite and nitrate levels, stable NO metabolites, were significantly increased in 
the pleural exudates at 4 h after carrageenan administration (C) if compared with sham mice (C). 3,4-
DHPEA-EA significantly reduced the carrageenan-induced elevation of nitrite and nitrate exudates 
levels (C). Data are expressed as mean ± S.E.M. from n 10 mice for each group. **, P < 0.01 versus sham 
group. ##, P < 0.01 versus carrageenan. 
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Figure 5. Effect of 3,4-DHPEA-EA (Ole aglycone) on carrageenan-induced nitrotyrosine formation, lipid 
peroxidation and PARP activation in the lung. No staining for nitrotyrosine is present in lung section from 
sham mice (A). Lung sections taken from carrageenan-treated mice treated with vehicle showed positive 
staining for nitrotyrosine, localized mainly in inflammatory cells (B). There was a marked reduction in the 
immunostaining for nitrotyrosine in the lungs of carrageenan-treated mice treated with 3,4-DHPEA-EA 
(C). Malondialdehyde (MDA) levels, an index of lipid peroxidation, were significantly increased in lung 
tissues 4 h after carrageenan administration (D), if compared with lung from sham mice (D). 3,4-DHPEA-
EA significantly reduced the carrageenan-induced elevation of MDA tissues levels (D). Lung sections 
taken from carrageenan-treated mice showed positive staining for PAR (F). There was a marked reduction 
in the immunostaining for PAR in the lungs of carrageenan-treated mice treated with 3,4-DHPEA-EA (G). 
Lung section from sham mice showed no staining for PAR (E). The figure is representative of at least 3 
experiments performed on different experimental days. Data are expressed as mean ± S.E.M. from n 10 
mice for each group. **, P < 0.01 versus sham group. ##, P < 0.01 versus carrageenan. 
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2.3. Discussion  
All of the above findings are in support of the view that 3,4-DHPEA-EA attenuates the degree 
of acute inflammation in the mouse. What, then, is the mechanism by which ole reduces acute 
inflammation? One consequence of increased oxidative stress is the activation and inactivation 
of redox-sensitive proteins (Bowie & O’Neill, 2000). Recent studies have observed that the 
acute consumption of olive oil decreased the activation of NF- κB system on mononuclear cells 
from healthy men (Perez-Martinez et al., 2007) and that 3,4-DHPEA-EA, trans-resveratrol, and 
hydroxytyrosol incubated with human umbilical vein endothelial cells inhibit LPS-triggered 
NF- κB and AP-1 activation (Carluccio et al., 2003). Moreover, various experimental evidence 
have clearly suggested that NF- κB plays a central role in the regulation of many genes 
responsible for the generation of mediators or proteins in acute lung inflammation associated 
with carrageenan administration (Cuzzocrea et al., 2006) such us TNF-α, IL-1β, nitric oxide 
synthase inducible (iNOS) and COX-2. By inhibiting the activation of NF- κB, the production 
of joint destructive inflammatory mediators may be reduced as well. In this regard, Miles et al., 
demonstrated that ole glycoside significantly decreased the concentration of IL-1β in LPS-
stimulated human whole blood cultures.  Therefore, this study also demonstrates that 3,4-
DHPEA-EA attenuates the TNF-α and IL-1β production in the lung of carrageenan-treated 
mice. In addition, recent studies also showed that the potential cardioprotective activity of 
oleuropein in acute cardiotoxicity induced by doxorubicin treatment was determined in vivo 
in rats (Andreadou et al., 2007) by inhibiting lipid peroxidation products, decreasing oxidative 
stress and reducing iNOS in cardiomyocytes. We show here that NO levels, evaluated as 
NO2/NO3 and MDA levels which is the products of lipid peroxidation, were increased at 4h 
after carrageenan injection while 3,4-DHPEA-EA decreased the levels of NO and MDA. For 
many years, much attention has been paid to the effects of NO in respiratory diseases 26 but 
recently, the focus has been shifted toward RNS in general, and to peroxynitrite (ONOO−) in 
particular (Sadeghi-Hashjin et al., 1998). To probe the pathological contributions of ONOO− to 
acute lung injury we have used the appearance of nitrotyrosine staining in the inflamed tissue. 
We have observed here that the immunoassaying of nitrotyrosine is reduced in  the lung of 
carrageenan-treated mice and treated with 3,4-DHPEA-EA. Therefore, the inhibition of 
nitrotyrosine formation by oleuropein described in the present study is most likely attributed 
to the strong antioxidant activity of ole. During inflammation initiation, circulating leukocytes 
must first be able to adhere selectively and efficiently to vascular endothelium. This process is 
facilitated by induction of vascular cell adhesion molecules on the inflamed endothelium, such 
as vascular cell adhesion molecule VCAM-1, ICAM-1, E-selectin demonstrated that 3,4-
DHPEA-EA was a more potent inhibitor of adhesion molecule expression on cultured human 
endothelial cells than was the glycoside(Carluccio et al., 2003). Furthermore, the absence of an 
increased expression of the adhesion molecule in the lung from CAR mice treated with 3,4-
DHPEA-EA was correlated with the reduction of leukocyte infiltration as assessed by the 
specific granulocyte enzyme MPO and with the attenuation of the lung tissue damage as 
evaluated by histological examination. Several studies also showed that in the auricular edema 
induced by either arachidonic acid (AA) or 12-O-tetradecanoylphorbol acetate (TPA), the 
topical application of the olive oil compounds such as ole also produced an inhibition of the 
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MPO in the inflamed tissue (de la Puerta et al., 2000). Various studies have demonstrated that 
PARP activation after single DNA strand breakage induced by ROS plays an important role in 
the process of acute lung injury (Szabo et al., 1998). In this study we confirm the increase in 
PAR formation in the lung tissues from carrageenan-treated mice as well as that 3,4-DHPEA-
EA treatment attenuates PARP activation. In this regard, several studies demonstrated that 
hydroxytyrosol, a hydrolysis product of 3,4-DHPEA-EA, also exerts an inhibitory effect on 
peroxynitrite-dependent DNA base modifications and tyrosine nitration (Deiana et al., 1999). 
Similarly, Salvini et al. (2006) showed a 30% reduction of oxidative DNA damage in peripheral 
blood lymphocytes during intervention on postmenopausal women with virgin olive oil 
containing high amounts of phenols. In conclusion, concomitant with inflammation is the 
generation of free radicals, which increase oxidation of proteins and lipids, resulting in signals 
that trigger more inflammation. Taken together, the results of the present study enhance our 
understanding of the role of ROS generation in the pathophysiology of carrageenan-induced 
pleurisy implying that olive oil compounds such as 3,4-DHPEA-EA may be useful in the 
therapy of acute inflammation. 
3. 3,4-DHPEA-EA and chronic inflammation 
Premise - Reactive oxygen species (ROS) are produced in cells by several physiological and 
environmental stimulations, such as infections, ultraviolet radiation and pollutants, known 
collectively as oxidants. Interestingly, ROS have also been considered as risk and enhancer 
factors for autoimmune diseases (Filippin et al., 2008) as there is a significant relation 
between the oxidative stress and such diseases (Filippin et al., 2008; Avalos et al., 2007). 
Rheumatoid arthritis (RA) is an autoimmune disease characterized by the sequestration of 
various leukocyte subpopulations within both the developing pannus and synovial space. 
The chronic nature of this disease results in multiple joint inflammation with subsequent 
destruction of joint cartilage and erosion of bone. While this disease has a worldwide 
distribution, its pathogenesis is not clearly understood (Harris, 1990). Type II collagen-
induced arthritis (CIA) in the mouse has proven to be a useful model of RA, as it possesses 
many of the cell and humoral immunity characteristics found in human RA (Holmdahl et al., 
1990). The pathogenesis of CIA is dependent upon the host's response to type II collagen 
challenge and the subsequent generation of antibodies that recognizes collagen rich joint 
tissue (Holmdahl et al., 1990). The chronic activities initiated by immune complexes trigger a 
variety of cell-mediated and humoral events. Moreover, the recruitment and activation of 
neutrophils, macrophages, and lymphocytes into joint tissues and the formation of the 
pannus are hallmarks of the pathogenesis of both CIA and human RA. Recently, it has been 
demonstrated that interleukin (IL)-8, macrophage inflammatory protein (MIP)-lα, MIP-1β, 
and RANTES are differentially chemotactic for lymphocyte subsets (Taub et al., 1993). 
Chemokines may play prominent roles in RA, as neutrophil and mononuclear cell 
stimulation and activation are prevalent in this disease. Concomitant with inflammation is 
the generation of ROS (Trichopoulou et al., 2003)which increase oxidation of proteins and 
lipids, resulting in signals that trigger more inflammation. Thus, the study model was 
designed to evaluate the effects of 3,4-DHPEA-EA in a mice model of chronic inflammation 
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(development of CIA in the mice). We have evaluated the following endpoints of the 
inflammatory process: (1) clinical score; (2) body weight; (3) inducible oxide nitric synthase 
(iNOS) and cyclooxygenase expression (COX-2); (4) nitrotyrosine formation and activation 
of the nuclear enzyme poly (ADP-ribose) polymerase (PARP); (5) cytokine and chemokines 
production; (6) neutrophil infiltration; (7) joint histopathology. 
Animals - DBA/1J mice (9 weeks, Harlan Nossan, Italy) were used for these studies. The 
animals were housed in a controlled environment and provided with standard rodent chow 
and water. Animal care was in compliance with Italian regulations on protection of animals 
used for experimental and other scientific purposes (Dlgs 116/92) as well as with the EEC 
regulations (O.J. of E.C. L 358/1 12/18/1986). 
Experimental Design - Mice were divided into the following four experimental groups: (i) 
CIA-Control; mice were subjected to collagen-induced arthritis (as described below) and 
administered 200 µl of 10% ethanol solution (i.p., vehicle for 3,4-DHPEA-EA) every 24 h, 
starting from day 25 (n = 20); (ii) CIA-3,4-DHPEA-EA; mice subjected to collagen-induced 
arthritis (as described below) were administered 3,4-DHPEA-EA (40 µM/kg, i.p.) every 24 h, 
starting from day 25 (n = 20); (iii) Sham-Control; mice subjected to an intradermal injection 
at the base of the tail of 100 µl of 0.01 M acetic acid instead of the emulsion containing 100 
µg of CII, were treated with 200 µl of 10% ethanol solution (i.p., vehicle for 3,4-DHPEA-EA), 
every 24 h starting from day 25 (n = 20); (iv) Sham-3,4-DHPEA-EA; mice subjected to an 
intradermal injection at the base of the tail of 100 µl of 0.01 M acetic acid instead of the 
emulsion containing 100 µg of CII, were administered 3,4-DHPEA-EA (40 µM/kg, i.p.), 
every 24 h starting from day 25 (n = 20). The dose of 3,4-DHPEA-EA used here to reduce 
joint injury was chosen based on a previous study (Procopio A, et al., 2009). Collagen-
induced arthritis (CIA) is induced in mice by two consecutive (interval 21 days) intradermal 
injection of 100 µl of the emulsion (containing 100 µg of bovine type II collagen) (CII) and 
complete Freund's adjuvant (CFA) at the base of the tail. Mice develop erosive hind paw 
arthritis with macroscopic clinical evidence of CIA as peri-articular erythema and edema in 
the hind paws. The incidence of CIA is 100% by day 27 in the CII challenged and the 
severity of CIA progressed over a 35-day period with a reabsorption of bone. The 
histopathology of CIA include erosion of the cartilage at the joint. 
Induction of CIA - Bovine CII was dissolved in 0.01 M acetic acid at a concentration of 2 
mg/ml by stirring overnight at 4°C. Dissolved CII was frozen at -70ºC until use. Complete 
Freund's adjuvant (CFA) was prepared by addition of Mycobacterium tuberculosis H37Ra 
at a concentration of 5 mg/ml. Before injection, CII was emulsified with an equal volume of 
CFA. CIA was induced as previously described (Szabo et al., 1998). On day 1, mice were 
injected intradermally at the base of the tail with 100 µl of the emulsion containing 100 µg of 
CII. On day 21, a second injection of CII in CFA was administered. 
Clinical assessment of CIA - The development of arthritis in mice in all experimental groups was 
evaluated daily starting from day 20 after the first intradermal injection by using a 
macroscopic scoring system: 0 = no signs of arthritis; 1 = swelling and/or redness of the paw or 
one digit; 2 = two joints involved; 3 = more than two joints involved; and 4 = severe arthritis of 
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the entire paw and digits (Szabo et al., 1998). Arthritic index for each mouse was calculated by 
adding the four scores of individual paws. Clinical severity was also determined by 
quantitating the change in the paw volume using plethysmometry (model 7140; Ugo Basile). 
Histological examination - On day 35, animals were sacrificed while they were under 
anesthesia (sodium pentobarbital, 45 mg/kg, i.p), and paws and knees were removed and 
fixed in 10% formalin. The paws were then trimmed, placed in decalcifying solution for 24 
h, embedded in paraffin, sectioned at 5 µm, stained with hematoxylin/eosin and Masson's 
trichrome stain and studied using light microscopy (Dialux 22 Leitz). 
Immunohistochemical localization of nitrotyrosine, Poly ADP Ribose (PAR), iNOS, and COX-2 - On 
day 35, the joints were trimmed, placed in decalcifying solution for 24 h and 8 µm sections 
were prepared from paraffin embedded tissues. After deparaffinization, endogenous 
peroxidase was quenched with 0.3% H2O2 in 60% methanol for 30 min. The sections were 
permeabilized with 0.1% Triton X-100 in PBS for 20 min. Non-specific adsorption was 
minimized by incubating the section in 2% normal goat serum in phosphate buffered saline for 
20 min. Endogenous biotin or avidin binding sites were blocked by sequential incubation for 
15 min with avidin and biotin. Sections were incubated overnight with 1) anti-rabbit 
polyclonal antibody directed at iNOS (1:1000 in PBS, v/v) (DBA, Milan, Italy) or 2) anti-COX-2 
goat polyclonal antibody (1:500 in PBS, v/v) or 3) anti- nitrotyrosine rabbit polyclonal antibody 
(1:1000 in PBS, v/v) or 4) with anti-PAR goat polyclonal antibody rat (1:500 in PBS, v/v) or 5). 
Controls included buffer alone or non-specific purified rabbit IgG. Specific labeling was 
detected with a biotin-conjugated goat anti-rabbit IgG (for nitrotyrosine and iNOS) or with a 
biotin-conjugated goat anti-rabbit IgG (for PAR and COX-2) and avidin-biotin peroxidase 
complex. In order to confirm that the immunoreaction for the nitrotyrosine was specific some 
sections were also incubated with the primary antibody (anti-nitrotyrosine) in the presence of 
excess nitrotyrosine (10 mM) to verify the binding specificity. To verify the binding specificity 
for PAR, COX-2 and iNOS, some sections were also incubated with only the primary antibody 
(no secondary) or with only the secondary antibody (no primary). In these situations, no 
positive staining was found in the sections indicating that the immunoreaction was positive in 
all the experiments carried out. Immunocytochemistry photographs (N=5) were assessed by 
densitometry by using Optilab Graftek software on a Macintosh personal computer. 
Measurement of cytokines - Tumor Necrosis Factor-α (TNF-α) levels were evaluated in the 
plasma from CIA and sham mice as previously described (Cuzzocrea et al., 2006). The assay 
was carried out using a colorimetric commercial ELISA kit (Calbiochem-Novabiochem Co., 
Milan, Italy) with a lower detection limit of 10 pg/ml. 
Measurement of chemokines - Levels of chemokines MIP-1α and MIP-2 were measured in the 
aqueous joint extracts. Briefly, joint tissues were prepared by first removing the skin and 
separating the limb below the ankle joint. Joint tissues were homogenized on ice in 3 ml 
lysis buffer (PBS containing: 2 mM PMSF, and 0,1 mg/ml [final concentration], each of 
aprotinin, antipain, leupeptin, and pepstatin A) using Polytron (Brinkinarm Instr., 
Westbury, NY). The homogenized tissues were then centrifuged at 2,000 g for 10 min. 
Supernatant were sterilized with a millipore filter (0.2 µm) and stored at –80oC until 
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analyzed. The extracts usually contained 0.2-1.5 mg protein/ml, as measured by protein 
assay kit (Pierce Chemical Co., Rockford, IL). The levels of MIP-1α and MIP-2 were 
quantified using a modification of a double ligand method, as previously described 
(Kasama et al., 1994). Briefly, flat-bottomed 96- well microtiter plates were coated with 50 
µl/well of rabbit anti-cytokine antibodies (1 µg/ml in 0.6 mol/liter NaCl, 0.26 mol/liter H3BO4 
and 0.08 N NaOH, pH 9.6) for 16 h at 4°C, and then washed with PBS, pH 7.5, 0.05% Tween 
20 (wash buffer). Nonspecific binding sites on microtiter plates were blocked with 2% BSA 
in PBS and incubated for 90 min at 37°C. Plates were rinsed four times with wash buffer, 
and diluted aqueous joint samples (50 µl) were added, followed by incubation for 1 h at 
37°C. After washing of plates, chromogen substrate was added. The plates were incubated 
at room temperature to the desired extinction, after which the reaction was terminated with 
50 µl/well of 3 M H2SO4 solution. The plates were then read at 490 nm in an ELISA reader. 
This ELISA method consistently had a sensitivity limit of ~30 pg/ml. 
Myeloperoxidase (MPO) assay - Neutrophil infiltration to the inflamed joints was indirectly 
quantitated using an MPO assay, as previously described for neutrophil elicitation (Mullane 
et al., 1985). Tissue was prepared as described above and placed in a 50 mM phosphate 
buffer (pH = 6.0) with 5% hexadecyltrimethyl ammonium bromide (Sigma Chemical Co.). 
Joint tissues were homogenized, sonicated, and centrifuged at 12,000 g for 15 min at 4ºC. 
Supernatants were assayed for MPO activity using a spectrophotometric reaction with O-
dianisidine hydrochloride (Sigma Chemical Co.) at 460 nm. 
Materials - 3,4-DHPEA-EA was obtained from Merck Biosciences (Calbiochem, Beecham, 
Nottingham, UK). Unless otherwise stated, other compounds were obtained from Sigma-
Aldrich Company (Milan, Italy). All chemicals were of the highest commercial grade 
available. All stock solutions were prepared in nonpyrogenic saline (0.9% NaCl; Baxter 
Healthcare Ltd., Thetford, Norfolk, U.K.) or 10% ethanol (Sigma-Aldrich). 
Data analysis - All values in the figures and text are expressed as mean ± standard error 
(s.e.m.) of the mean of n observations. For the in vivo studies n represents the number of 
animals studied. In the experiments involving histology or immunohistochemistry, the 
figures shown are representative of at least three experiments (histological or 
immunohistochemistry coloration) performed on different experimental days on the tissue 
sections collected from all the animals in each group. Data sets were examined by one- or 
two-way analysis of variance, and individual group means were then compared with 
Student's unpaired t test. For the arthritis studies, Mann-Whitney U test (two-tailed, 
independent) was used to compare medians of the arthritic indices (Szabo et al., 1998). A p-
value of less than 0.05 was considered significant. 
3.1. Results 
Effect of 3,4-DHPEA-EA on joint injury during experimental arthritis - To imitate the clinical 
scenario of RA, mice were subjected to CIA. CIA developed rapidly in mice immunized with 
CII and clinical signs (periarticular erythema and edema) (Fig. 6B) of the disease first appeared 
in hind paws between 24 and 26 days post-challenge (Fig. 6D) leading to a 100% incidence of 
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CIA at day 28 (Fig. 6D). Hind paw erythema and swelling increased in frequency and severity 
in a time-dependent mode with maximum arthritis indices of approximately 10 observed 
between day 29 to 35 post immunization (Fig. 6D) in CIA-control mice. 3,4-DHPEA-EA 
treatment demonstrated a significant reduction of joint inflammation, as identified by a 
significant reduction in the incidence of arthritis (Figure 6C). CIA-3,4-DHPEA-EA mice 
showed a 40% reduction in the development of arthritis and a significantly lower arthritis 
index compared to CIA- control mice (Fig. 6D). There was no macroscopic evidence of either 
hind paw erythema or edema in the sham-control group mice (Fig. 6A and D). The data in 
Figure 6E demonstrate a time-dependent increase in hind paw volume (each value represents 
the mean of both hind paws). The CIA-3,4-DHPEA-EA mice showed a significant reduction of 
paw edema formation when compared to CIA-control mice (Fig. 6E). No increase in hind paw 
volume over time was observed in the sham-control mice (Fig. 6E). The rate and the absolute 
gain in body weight were comparable in sham-control and CIA-control mice in the first week 
(Fig. 6F). From day 25, the CII-challenged mice gained significantly less weight than the sham-
control mice, and this trend continued through to day 35. 3,4-DHPEA-EA treatment 
determined a significant increase of the weight gain compared with the vehicle-treatment in 
CIA-control mice (Fig. 6F). The histological evaluation (on day 35) of the joint from CIA-
control mice (Fig. 7B) revealed signs of severe arthritis, with inflammatory cell infiltration and 
bone erosion. The histological alterations of joint were significantly reduced in 3,4-DHPEA-
EA-treated mice (Fig. 7C). Moreover Masson’s trichrome stain reveals decreased collagen (blue 
stain) in bone and cartilage of arthritic joint due to bone erosion and cartilage degradation in 
CIA-control mice (Fig. 7E). The alterations of joint were significantly reduced in 3,4-DHPEA-
EA-treated mice (Fig. 7F). There was no evidence of pathology in the sham-control mice (Fig. 
7A and D). The histological score (Fig. 7G) was determined by an independent observer. 
Effect of 3,4-DHPEA-EA on cytokines, chemokine expression and neutrophil infiltration - We initiated 
studies to assess the effect of 3,4-DHPEA-EA on the expression of chemokines in the aqueous 
joint extracts during the development of CIA. As shown in Fig. 8, A and B, the expression of 
MIP-1α and MIP-2, measured by ELISA, was significantly increased in the joint 35 days after 
CII immunization. MIP-1α and MIP-2 levels in CIA-3,4-DHPEA-EA mice on day 35 were 
significantly reduced in a dose-dependent manner in comparison with those in vehicle treated 
CIA-control mice. Assessment of neutrophil infiltration into the inflamed joint tissue was 
performed by measuring the activity of MPO. It was significantly elevated 35 days after CII 
immunization in vehicle-treated CIA-control mice (Fig. 8F), whereas in the CIA-3,4-DHPEA-
EA group, MPO activity was markedly reduced in a dose-dependent manner (Fig. 8F). To test 
whether 3,4-DHPEA-EA modulates the inflammatory process through the regulation of 
cytokine secretion, we analyzed the plasma levels of the proinflammatory cytokines TNF-α, 
IL-1β, and IL-6. A substantial increase in TNF-α, (Fig. 8C), IL-1β (Fig. 8D), and IL-6 (Fig. 8E) 
production was found in CIA-control mice 35 days after CII immunization. Levels of TNF-α 
(Fig. 8C), IL-1β (Fig. 8D), and IL-6 (Fig. 8E) were significantly reduced in a dose-dependent 
manner in CIA-3,4-DHPEA-EA mice in comparison to CIA-control mice. 
Effect of 3,4-DHPEA-EA treatment on iNOS, COX-2, PGE2, nitrotyrosine, and PAR formation - 
Immunohistochemical analysis of the tibiotarsal joint sections obtained from CIA-control 
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mice revealed positive staining for iNOS (Fig. 10, A and A1) and COX-2 (Fig. 9, A and A1), 
which were primarily localized in inflammatory cells. In contrast, staining for iNOS (Fig. 
10B) and COX-2 (Fig. 9B) was markedly reduced in the tibiotarsal joints of CIA-3,4-DHPEA- 
EA (40 µg/kg) mice. No staining for either iNOS or COX-2 was detected in the tibiotarsal 
joints obtained from sham control mice (data not shown). Moreover, we also evaluated the 
 
Figure 6. Effect of 3,4-DHPEA-EA (Ole aglycone) on the clinical expression of CIA and on body weight. 
A, no clinical signs were observed in sham mice. CIA developed rapidly in mice immunized with CII 
and clinical signs such as periarticular erythema and edema (B) were seen with a 100% incidence of CIA 
at day 28 (D). E, hind paw erythema and swelling increased in frequency and severity in a time 
dependent mode. CIA-3,4-DHPEA-EA mice demonstrated a significant reduction in the clinical signs of 
CIA (C), leading to a decrease in the incidence of arthritis in a dose-dependent manner (D). Swelling of 
hind paws (F) over time was measured at 2-day intervals. G, beginning on day 25, the CII-challenged 
mice gained significantly less weight and this trend continued through day 35. CIA-3,4-DHPEA-EA 
mice demonstrated a significant reduced incidence of weight loss (G) as well as less paw edema in a 
dose dependent manner (F). The figure is representative of all the animals in each group. Values are 
means ± S.E.M. of 20 animals for each group. **, P < 0.01 versus sham-control; °, P < 0.01 versus CIA. 
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Figure 7. Morphological changes of CIA. Representative hematoxylin and eosin-stained section of joint 
was examined by light microscopy. The histological evaluation (on day 35) of joint from CIA-control 
mice (B and G) revealed signs of severe arthritis, with inflammatory cell infiltration and bone erosion. 
The histological alterations of the joint were significantly reduced in the tissues from CIA-3,4-DHPEA-
EA (40 µg/kg)-treated mice (C and G). Masson’s trichrome stain reveals decreased collagen in bone and 
cartilage of arthritic joint due to bone erosion and cartilage degradation in CIA-control mice (E and G). 
The alterations of joint were significantly reduced in 3,4-DHPEA-EA (40 µg/kg)-treated mice (F and G). 
There was no evidence of pathology in the sham-control mice (A, D, and G). The histological score (G) 
was made by an independent observer. The figure is representative of at least three experiments 
performed on different experimental days. Values are means ± S.E.M. of 20 animals for each group. **, P 
< 0.01 versus sham-control; °, P < 0.01 versus CIA. 
levels of PGE2, the metabolite of COX-2, in the serum during the development of CIA. A 
substantial increase in PGE2 production was found in CIA-control mice 35 days after CII 
immunization (Fig. 9E). Levels of PGE-2 were significantly reduced in CIA-3,4-DHPEA-EA 
mice in a dose dependent manner compared with those in CIA-control mice (Fig. 9E). The 
release of free radicals and oxidant molecules during chronic inflammation has been 
suggested to contribute significantly to the tissue injury (Cuzzocrea et al., 2001). On day 35, 
positive staining for nitrotyrosine, a marker of nitrosative injury, was found in the tibiotarsal 
joints of vehicle-treated CIA-control mice (Fig. 11, A and A1). 3,4-DHPEA-EA (40 µg/kg) 
treatment significantly reduced the formation of nitrotyrosine (Fig. 11B). 
Immunohistochemical analysis of joint sections obtained from CII-challenged mice revealed 
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positive staining for PAR (Fig. 12, A and A1). In contrast, no positive PAR was found in the 
tibiotarsal joints of CII-challenged mice treated with 3,4-DHPEA-EA (40 µg/kg) (Fig. 12B). 
There was no staining for either nitrotyrosine or PAR in the tibiotarsal joints obtained from 





Figure 8. Effect of 3,4-DHPEA-EA (Ole aglycone) treatment on cytokine and chemokine expression and 
neutrophil infiltration. A substantial increase in the expression of MIP-1 (A), MIP-2 (B), MPO activity 
(F), plasma TNF-α (C), IL-1β (D), and IL-6 levels (E) was found in CIA-control mice 35 days after CII 
immunization. CIA-3,4-DHPEA-EA mice demonstrated a significant reduction in the expression of 
MIP-1 (A), MIP-2 (B), MPO activity (F), plasma TNF-α (C), IL-1β (D), and IL-6 levels in a dose 
dependent manner (E). Values are means ± S.E.M. of 20 animals for each group. **, P < 0.01 versus sham 
control; °, P < 0.01 versus CIA-control. ND, not detectable. 
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Figure 9. Effect of 3,4-DHPEA-EA (Ole aglycone) treatment on COX-2 immunostaining and on serum PGE2 
levels. A marked increase in COX-2 (A and in particular A1) staining was evident in the paw 35 days after 
initiation of CIA. There was a marked reduction in the immunostaining for COX-2 (B) in the paw of CIA-3,4-
DHPEA-EA (40 µg/kg) mice. To verify the binding specificity for COX-2, some sections were also incubated 
with only the secondary antibody (no primary antibody). No positive staining for COX-2 was found in the 
sections indicating that the immunoreaction was positive (see negative control C). In addition, a marked 
increase of PGE2 levels was found in the serum of CIA control mice 35 days after CII immunization (E). The 
treatment with 3,4-DHPEA-EA also caused a significant reduction in a dose-dependent manner of the serum 
levels of the metabolite of COX-2 (E). The figure is representative of at least three experiments performed on 
different experimental days. Densitometry analysis of immunocytochemistry photographs (n = 5) for COX-2 
from paw section was assessed (D). The assay was performed by using Optilab Graftek software on a 
Macintosh personal computer (CPU G3-266). Data are expressed as a percentage of total tissue area. **, P < 
0.01 versus sham control; °, P < 0.01 versus CIA. ND, not detectable. 
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Figure 10. Effect of 3,4-DHPEA-EA (Ole aglycone) treatment on iNOS immunostaining. A marked 
increase in iNOS (A and in particular A1) staining was evident in the paw 35 days after initiation of 
CIA. There was a marked reduction in the immunostaining for iNOS (B) in the paw of CIA-3,4-DHPEA-
EA (40 µg/kg) mice. To verify the binding specificity for iNOS, some sections were also incubated with 
only the secondary antibody (no primary antibody). No positive staining for iNOS was found in the 
sections, indicating that the immunoreaction was positive (see negative control C). The figure is 
representative of at least three experiments performed on different experimental days. Densitometry 
analysis of immunocytochemistry photographs (n = 5) for iNOS from paw section was assessed (D). The 
assay was performed by using Optilab Graftek software on a Macintosh personal computer (CPU G3-
266). Data are expressed as a percentage of total tissue area. **, P < 0.01 versus sham-control; °, P < 0.01 
versus CIA. ND, not detectable. 
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Figure 11. Effect of 3,4-DHPEA-EA (Ole aglycone) treatment on nitrotyrosine immunostaining. A 
marked increase in nitrotyrosine (A and in particular A1) staining was evident in the paw 35 days after 
initiation of CIA. There was a marked reduction in the immunostaining for nitrotyrosine (B) in the paw 
of CIA-3,4-DHPEA-EA (40 µg/kg)-treated mice. To verify the binding specificity for nitrotyrosine, some 
sections were also incubated with only the secondary antibody (no primary antibody). No positive 
staining for nitrotyrosine was found in the sections, indicating that the immunoreaction was positive 
(see negative control C). The figure is representative of at least three experiments performed on 
different experimental days. Densitometry analysis of immunocytochemistry photographs (n = 5) for 
nitrotyrosine from paw section was assessed (D). The assay was performed by using Optilab Graftek 
software on a Macintosh personal computer (CPU G3-266). Data are expressed as a percentage of total 
tissue area. **, P < 0.01 versus sham control; °, P < 0.01 versus CIA. ND, not detectable. 
 
Oleuropein an Olive Oil Compound in Acute and Chronic Inflammation Models: Facts and Perspectives 309 
 
Figure 12. Effect of 3,4-DHPEA-EA (Ole aglycone) treatment on PARP immunostaining. A marked 
increase in PARP (A and in particular A1), staining was evident in the paw 35 days after initiation of 
CIA. There was a marked reduction in the immunostaining for PARP (B) in the paw of CIA-3,4-
DHPEA-EA (40 g/kg)-treated mice. To verify the binding specificity for PARP, some sections were also 
incubated with only the secondary antibody (no primary antibody). No positive staining for PARP was 
found in the sections, indicating that the immunoreaction was positive (see negative control C). The 
figure is representative of at least three experiments performed on different experimental days. 
Densitometry analysis of immunocytochemistry photographs (n = 5) for PARP from paw section was 
assessed (D). The assay was performed by using Optilab Graftek software on a Macintosh personal 
computer (CPU G3-266). Data are expressed as a percentage of total tissue area. **, P <0.01 versus sham-
control; °, P<0.01 versus CIA. ND, not detectable. 
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3,4-DHPEA-EA Inhibits the Progression of Established Arthritis - To confirm that 3,4-
DHPEA-EA exerts beneficial effects in the experimental model of collagen-induced arthritis, 
we have also evaluated its effect in a therapeutic regimen of post-treatment (40 µg/kg), 
starting the treatment at day 28. CIA-3,4-DHPEA-EA post-treatment mice also showed a 
reduction in the development of arthritis and a significantly lower arthritis score compared 
with those in CIA-control mice as shown in Fig. 13A. 3,4-DHPEA-EA post-treatment also 
significantly reduced paw edema formation (Fig. 13B). In addition, 3,4-DHPEA-EA post-
treated mice showed significantly reduced histological alterations of the tibiotarsal joint as 
shown in the histological score (Fig. 13C) and increased body weight (Fig. 13D). 
 
 
Figure 13. Effect of 3,4-DHPEA-EA (Ole aglycone) post-treatment on joint inflammation. Starting the 
treatment at day 28, we have also demonstrated that 3,4-DHPEA-EA post-treatment (40 µg/kg) caused a 
significantly lower arthritis score (A) and a reduction of foot increase (B) compared with the CIA-
control. In addition, we have also shown a reduction in the histological damage (C) and increased body 
weight (D) in 3,4-DHPEA-EA -treated mice. Data are expressed as a percentage of total tissue area. **, 
P< 0.01 versus sham-control; °, P< 0.01 versus CIA. 
3.2. Discussion  
Rheumatoid arthritis is an inflammatory disease characterized by chronic inflammation of 
the synovial joints associated with proliferation of synovial cells and infiltration of activated 
immunoinflammatory cells, including memory T cells, macrophages, and plasma cells, 
leading to progressive destruction of cartilage and bone (Hitchon et al., 2004). Another 
central feature of RA synovitis is the transformation of fibroblast-like synovial cells into 
autonomously proliferating cells with a tissue-infiltrating nature, forming hyperplastic 
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tissue with the potential for bone erosion and cartilage degradation known as pannus 
(Filippin et al., 2008). Therefore, it is necessary to establish and characterize experimental 
animal models to assess cellular and molecular events that contribute to the pathogenesis of 
joint inflammation. Of interest, CII-induced arthritis in the mouse has proven to be a useful 
model, because it possesses many of the cellular and humoral immune events found in 
human rheumatoid arthritis. Oxidative stress describes an imbalance between ROS 
synthesis and antioxidants. Many studies have demonstrated a role of ROS in the 
pathogenesis of inflammatory chronic arthropathies, such as rheumatoid arthritis (Filippin 
et al., 2008). In this regard, we investigate here the effects of 3,4-DHPEA-EA, a hydrolysis 
product of oleuropein, in a mouse model of CII-induced arthritis. Although T-cell and 
antibody responses against CII are a crucial event for the initiation of CIA (Holmdahl et al., 
1989), it has been demonstrated that several cytokines also appear to direct cell-to-cell 
communication in a cascade fashion during the progression of CIA such as IL-1 (Hom et al., 
1992), TNF-α (Dong et al., 2010), and IL-6 (Ferraccioli et al., 2010). In addition, it has been 
demonstrated that monocyte chemotactic protein-1, MIP-α, MIP-1β, and regulated on 
activation normal T cell expressed and secreted are differentially chemotactic for 
lymphocyte subsets and are expressed in tissue from the inflamed joints of patients with 
rheumatoid arthritis (Koch et al., 1994). In this study, we have confirmed that the cytokines 
(TNF-α, IL-1β, and IL-6) as well as the chemokines (MIP-1α and MIP-2) are expressed at 
sites of inflamed joints and probably contribute in different capacities to the progression of 
chronic joint inflammation. Several cytokines, including TNF-α and IL-1β, are known 
initiators of the nuclear factor (NF- κB) activation cascade (Filippin et al., 2008) and are 
under its transcriptional control, constituting a positive feedback loop. Recent studies have 
observed that the acute consumption of olive oil decreased the activation of the NF- κB 
system on  mononuclear cells from healthy men (Perez-Martinez et al., 2007) and that 3,4-
DHPEA-EA, trans-resveratrol, and hydroxytyrosol incubated with human umbilical vein 
endothelial cells inhibit lipopolysaccharide-triggered NF- κB and activator protein-1 
activation (Carluccio et al., 2003). Of interest, using 3,4-DHPEA-EA, we have demonstrated 
an inhibition of the release of proinflammatory cytokines and chemokines and a reduction 
of leukocyte infiltration measured by MPO activity. Several studies also showed that the 
potential cardioprotective activity of oleuropein in acute cardiotoxicity induced by 
doxorubicin treatment was determined in vivo in rats (Andreadou et al., 2007) by inhibiting 
lipid peroxidation products, decreasing oxidative stress, and reducing iNOS in 
cardiomyocytes and that the olive oil polyphenols are capable of down-regulating COX-2 
expression in colonic cancer cells by a mechanism involving the early inhibition of p38 
mitogen-activated protein kinase and downstream inhibition of the transcription factor 
cAMP response element-binding protein (Corona et al., 2007). We show here that 3,4-
DHPEA-EA decreased iNOS and COX-2 expression by immunohistochemical staining and 
also reduced the levels of the metabolite of COX-2, PGE2, in the serum of 3,4-DHPEA-EA 
treated mice. Reactive nitrogen species, such as the peroxynitrite radical (ONOO_) generated 
by the reaction between O2 . and nitric oxide, can also cause oxidative damage (Soneja et al., 
2005). The addition of ONOO_ to body cells, tissues, and fluids leads to fast protonation, 
which may result in the depletion of -SH groups and other antioxidants, oxidation and  
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nitration of lipids, DNA disruption, and nitration and deamination of DNA bases (Filippin 
et al., 2008). In this report, an intense immunostaining of nitrotyrosine formation also 
suggested that a structural alteration of joint had occurred, most probably due to the 
formation of highly reactive nitrogen derivatives ROS produce strand breaks in DNA, which 
triggers energy-consuming DNA repair mechanisms and activates the nuclear enzyme 
poly(ADP-ribosyl) polymerase (PARP). There is various evidence that the activation of 
PARP may also play an important role in inflammation (Genovese et al., 2005). Continuous 
or excessive activation of PARP produces extended chains of ADP-ribose (PAR) on nuclear 
proteins and results in a substantial depletion of intracellular NAD and subsequently, 
ATP, leading to cellular dysfunction and, ultimately, cell death (Chiarugi, 2002). We 
demonstrate here that 3,4-DHPEA-EA treatment reduced the activation of PARP with a 
decrease in PAR expression in the joint during CIA. In this regard, several studies 
demonstrated that hydroxytyrosol, a hydrolysis product of 3,4-DHPEA-EA, also exerts an 
inhibitory effect on peroxynitrite-dependent DNA base modifications and tyrosine 
nitration (Deiana et al., 1999). Likewise, Salvini et al. (2006) showed a 30% reduction of 
oxidative DNA damage in peripheral blood lymphocytes during intervention in 
postmenopausal women with virgin olive oil containing high amounts of phenols. Thus, 
3,4-DHPEA-EA, given at the onset of the disease, reduced paw swelling, clinical score, 
and the histological severity of the disease when injected after the onset of clinical 
arthritis. Amelioration of joint disease was associated with near to full inhibition of 
cytokines as well as inhibition of neutrophil infiltration, which is a key player in RA. 
Therefore, 3,4-DHPEA-EA was also administered from day 28 after collagen 
immunization, targeting this early initiation phase of CIA. Then, with treatment starting 
at day 28, 3,4-DHPEA-EA post-treatment caused a significant reduction of inflamed joints 
collected at day 35. In conclusion, RA is a complex chronic inflammatory disease 
dependent on multiple interacting environmental and genetic factors, making it difficult 
to understand its pathogenesis and thereby to find effective therapies. Taken together, the 
results of the present study enhance our understanding of the role of ROS generation in 
the pathophysiology of CII-induced arthritis, implying that olive oil compounds such as 
3,4-DHPEA-EA may be useful in the therapy of inflammation. 
4. Overall conclusion 
Oxidative stress is described as an imbalance between ROS synthesis and antioxidant 
system in the mammal body where the normal production of oxidants is counteracted by 
several antioxidative mechanisms. Food constituents are the normal substrate for energy 
generation but a hypercaloric diet may result in higher ROS, thus inducing oxidative stress. 
Epidemiological studies have shown that populations consuming a predominantly olive oil-
based Mediterranean-style diet exhibit lower incidences of breast cancer and other chronic 
diseases than those eating a northern European or North American diet. Habitual high 
intakes of olive oil, especially virgin olive oil, provide a continuous supply of antioxidants, 
which may reduce oxidative stress via inhibition of lipid peroxidation, a factor that is 
currently linked to a host of diseases such as cancer, heart disease, and ageing. 
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